Titre : Phénylurées

Phénylurées : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Phénylurées : Questions médicales les plus fréquentes", "headline": "Phénylurées : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Phénylurées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-12", "dateModified": "2025-03-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Phénylurées" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dérivés du benzène", "url": "https://questionsmedicales.fr/mesh/D001555", "about": { "@type": "MedicalCondition", "name": "Dérivés du benzène", "code": { "@type": "MedicalCode", "code": "D001555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dérivés de la diphényl-urée", "alternateName": "Carbanilides", "url": "https://questionsmedicales.fr/mesh/D002224", "about": { "@type": "MedicalCondition", "name": "Dérivés de la diphényl-urée", "code": { "@type": "MedicalCode", "code": "D002224", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.202" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Imidocarbe", "alternateName": "Imidocarb", "url": "https://questionsmedicales.fr/mesh/D007095", "about": { "@type": "MedicalCondition", "name": "Imidocarbe", "code": { "@type": "MedicalCode", "code": "D007095", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.202.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Céliprolol", "alternateName": "Celiprolol", "url": "https://questionsmedicales.fr/mesh/D017272", "about": { "@type": "MedicalCondition", "name": "Céliprolol", "code": { "@type": "MedicalCode", "code": "D017272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.241" } } }, { "@type": "MedicalWebPage", "name": "Diuron", "alternateName": "Diuron", "url": "https://questionsmedicales.fr/mesh/D004237", "about": { "@type": "MedicalCondition", "name": "Diuron", "code": { "@type": "MedicalCode", "code": "D004237", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.397" } } }, { "@type": "MedicalWebPage", "name": "Linuron", "alternateName": "Linuron", "url": "https://questionsmedicales.fr/mesh/D008044", "about": { "@type": "MedicalCondition", "name": "Linuron", "code": { "@type": "MedicalCode", "code": "D008044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.515" } } } ], "about": { "@type": "MedicalCondition", "name": "Phénylurées", "alternateName": "Phenylurea Compounds", "code": { "@type": "MedicalCode", "code": "D010671", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Lin Hao", "url": "https://questionsmedicales.fr/author/Lin%20Hao", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China." } }, { "@type": "Person", "name": "Chun Wang", "url": "https://questionsmedicales.fr/author/Chun%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China. chunwang69@126.com." } }, { "@type": "Person", "name": "Qiuhua Wu", "url": "https://questionsmedicales.fr/author/Qiuhua%20Wu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China. qiuhuawu@126.com." } }, { "@type": "Person", "name": "Zhi Wang", "url": "https://questionsmedicales.fr/author/Zhi%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China." } }, { "@type": "Person", "name": "Weihua Liu", "url": "https://questionsmedicales.fr/author/Weihua%20Liu", "affiliation": { "@type": "Organization", "name": "College of Science, Hebei Agricultural University, Baoding 071001, Hebei, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.", "datePublished": "2023-07-20", "url": "https://questionsmedicales.fr/article/37511475", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijms241411715" } }, { "@type": "ScholarlyArticle", "name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.", "datePublished": "2023-03-07", "url": "https://questionsmedicales.fr/article/36894035", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1053/j.gastro.2023.02.044" } }, { "@type": "ScholarlyArticle", "name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.", "datePublished": "2023-02-28", "url": "https://questionsmedicales.fr/article/36855007", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12350-023-03202-w" } }, { "@type": "ScholarlyArticle", "name": "Optimal age to stop prostate cancer screening and early detection.", "datePublished": "2023-08-19", "url": "https://questionsmedicales.fr/article/37598870", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jcpo.2023.100443" } }, { "@type": "ScholarlyArticle", "name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.", "datePublished": "2022-10-03", "url": "https://questionsmedicales.fr/article/36121650", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ijc.34298" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Phénylurées", "item": "https://questionsmedicales.fr/mesh/D010671" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Phénylurées - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Phénylurées", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Phénylurées", "description": "Comment diagnostiquer une intoxication aux phénylurées ?\nQuels tests sont utilisés pour détecter les phénylurées ?\nQuels symptômes indiquent une exposition aux phénylurées ?\nLes phénylurées sont-elles détectables par imagerie ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Phénylurées", "description": "Quels sont les symptômes courants des phénylurées ?\nLes phénylurées provoquent-elles des réactions allergiques ?\nPeut-on avoir des symptômes neurologiques ?\nLes symptômes varient-ils selon la dose ?\nY a-t-il des symptômes à long terme ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Phénylurées", "description": "Comment prévenir l'exposition aux phénylurées ?\nLes travailleurs doivent-ils être formés ?\nDes contrôles réguliers sont-ils nécessaires ?\nLes enfants sont-ils plus à risque ?\nQuelles mesures de sécurité doivent être appliquées ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Phénylurées", "description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les phénylurées ?\nComment gérer les symptômes neurologiques ?\nLe traitement nécessite-t-il une hospitalisation ?\nY a-t-il des traitements préventifs ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Phénylurées", "description": "Quelles complications peuvent survenir ?\nLes phénylurées peuvent-elles causer des cancers ?\nY a-t-il des effets sur la reproduction ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Phénylurées", "description": "Quels sont les principaux facteurs de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes personnes âgées sont-elles plus à risque ?\nLes femmes enceintes doivent-elles être prudentes ?\nLes habitudes de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux phénylurées ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests sanguins et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les phénylurées ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux phénylurées ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des éruptions cutanées et des nausées." } }, { "@type": "Question", "name": "Les phénylurées sont-elles détectables par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne détecte pas les phénylurées, des tests biochimiques sont nécessaires." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les expositions potentielles aux phénylurées." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des phénylurées ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des vertiges et des troubles digestifs." } }, { "@type": "Question", "name": "Les phénylurées provoquent-elles des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des éruptions cutanées et des démangeaisons chez certains individus." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme des convulsions ou des troubles de la coordination peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Y a-t-il des symptômes à long terme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des effets neurologiques ou rénaux peuvent persister après une exposition prolongée." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux phénylurées ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits chimiques contenant des phénylurées et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle." } }, { "@type": "Question", "name": "Des contrôles réguliers sont-ils nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers de l'environnement de travail peuvent réduire les risques." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets des phénylurées." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être appliquées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des gants, des masques et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste en l'élimination de l'exposition et le soutien symptomatique." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les phénylurées ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment gérer les symptômes neurologiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anticonvulsivants peuvent être prescrits pour contrôler les convulsions." } }, { "@type": "Question", "name": "Le traitement nécessite-t-il une hospitalisation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une hospitalisation peut être nécessaire en cas de symptômes graves ou persistants." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition aux phénylurées est la meilleure prévention contre l'intoxication." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, rénales ou hépatiques peuvent se développer après exposition." } }, { "@type": "Question", "name": "Les phénylurées peuvent-elles causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien potentiel avec des cancers, mais des recherches sont nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des effets sur la reproduction ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des effets néfastes sur la reproduction ont été observés dans certains modèles animaux." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens médicaux réguliers et des tests de fonction organique sont recommandés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition professionnelle, l'utilisation de produits chimiques et la génétique sont des facteurs clés." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque d'effets néfastes." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets des phénylurées." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles être prudentes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes enceintes doivent éviter l'exposition en raison des risques pour le fœtus." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie saines peuvent réduire le risque d'effets néfastes." } } ] } ] }

Sources (10000 au total)

A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.

Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv... The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro... In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo... EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....

Optimal age to stop prostate cancer screening and early detection.

Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can... We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer... Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the... Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...

Ovarian Cancer-Self Assessment: An Innovation for Early Detection and Risk Assessment of Ovarian Cancer.

The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can... This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ... In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst... Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...

Integration of multiomics features for blood-based early detection of colorectal cancer.

Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o... In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me... This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv... Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...

Prospective cohort for early detection of liver cancer (Pearl): a study protocol.

Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir... This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ... Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings.... NCT05541601....